During Tuesday’s trading session, the shares of one of India’s fastest growing diagnostic service providers, both in radiology and pathology, jumped around 6.3 percent on BSE, after the company announced acquiring a 23.53 percent stake in Apulki Healthcare Private Limited.
Price Movement
With a market capitalisation of Rs. 2,499.5 crores, the shares of Krsnaa Diagnostics Limited hit an intraday high at Rs. 834.9 on BSE, up by nearly 6.3 percent, as against its previous closing price of Rs. 785.4. The stock has delivered positive returns of over 22 percent in one year, as well as about 10.4 percent returns in one month.
What’s the News
As per the latest regulatory filings with the stock exchanges, Krsnaa Diagnostics Limited has entered into a Share Purchase and Share Subscription Agreement (SPSS) and a Shareholders Agreement (SHA) with Apulki Healthcare Private Limited (AHPL) to acquire 23.53 percent equity shares in AHPL.
Through this acquisition, Krsnaa Diagnostics secures an exclusive partnership to operate and manage diagnostic services at AHPL’s hospitals. The total acquisition cost for the 23.53 percent stake amounts to Rs. 31.25 crore.
Also read: Cable stock jumps 6% after receiving work order from Adani Group
About the Target Entity
Apulki Healthcare Private Limited (AHPL) is engaged in the business of establishing, operating and maintaining hospitals, focusing on oncology and cardiology in the public-private partnership mode, having entered into agreements for a tenure of 30 years.
AHPL has an authorized share capital of Rs. 25 lakhs and a paid-up capital of Rs. 1 lakh. Incorporated in 2022, AHPL was formed in compliance with the terms for executing the Cancer and Cardiac Care Project.
Financials
Krsnaa Diagnostics reported a significant growth in revenue from operations, experiencing a year-on-year increase of nearly 10 percent, rising from Rs. 158.3 crores in Q3 FY24 to Rs. 174.5 crores in Q3 FY25. Likewise, during the same period, the company’s net profit increased from Rs. 13 crores to Rs. 19.4 crores, representing a growth of around 50 percent YoY.
About the Company
Krsnaa Diagnostics Limited is primarily engaged in the business of providing diagnostic services primarily in relation to pathology investigation, radiology investigation and tele-reporting.
The company now operates 49 NABL–accredited pathology laboratories in Government hospitals across seven states: Maharashtra, Punjab, Himachal Pradesh, Odisha, Assam, Manipur, and Rajasthan. Krsnaa expanded its presence by establishing 284 additional collection centers across India.
Written by Shivani Singh
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
